Breaking News Instant updates and real-time market news.

CRC

California Resources

$6.12 /

-0.655 (-9.68%)

15:04
02/26/20
02/26
15:04
02/26/20
15:04

California Resources options imply 30.6% move in share price post-earnings

Pre-earnings options volume in California Resources is 4.4x normal with puts leading calls 15:2. Implied volatility suggests the market is anticipating a move near 30.6%, or $1.89, after results are released. Median move over the past eight quarters is 8.8%.

  • 26

    Feb

CRC California Resources
$6.12 /

-0.655 (-9.68%)

08/05/19 Imperial Capital
California Resources price target lowered to $20 from $28 at Imperial Capital
05/13/19
California Resources upgraded to Outperform on valuation at Raymond James
05/13/19 Raymond James
California Resources upgraded to Outperform at Raymond James
04/12/19 Goldman Sachs
Goldman downgrades California Resources, Chesapeake to Sell, upgrades Murphy

TODAY'S FREE FLY STORIES

On The Fly
Box Office Battle: 'Raya' wins biggest weekend since shutdown » 18:15
03/07/21
03/07
18:15
03/07/21
18:15
T

AT&T

$29.62 /

+0.705 (+2.44%)

, CMCSA

Comcast

$55.03 /

+1.045 (+1.94%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, SNE

Sony

$104.07 /

+2.22 (+2.18%)

, LGF.A

Lionsgate

$17.31 /

+0.22 (+1.29%)

, LGF.B

Lionsgate

$14.89 /

+0.21 (+1.43%)

, DIS

Disney

$189.90 /

+2.18 (+1.16%)

, VIACA

ViacomCBS

$74.40 /

+2.64 (+3.68%)

, VIAC

ViacomCBS

$74.22 /

+2.35 (+3.27%)

Disney’s (DIS) "Raya…

ShowHide Related Items >><<
T AT&T
$29.62 /

+0.705 (+2.44%)

CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SNE Sony
$104.07 /

+2.22 (+2.18%)

LGF.A Lionsgate
$17.31 /

+0.22 (+1.29%)

LGF.B Lionsgate
$14.89 /

+0.21 (+1.43%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

VIACA ViacomCBS
$74.40 /

+2.64 (+3.68%)

VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

T AT&T
$29.62 /

+0.705 (+2.44%)

03/05/21 JPMorgan
JPMorgan sees AT&T rallying into analyst meeting, but not after
03/04/21 Wells Fargo
Wells Fargo sees Dycom near-term growth priced in, cuts rating to Equal Weight
02/25/21
Fly Intel: Pre-market Movers
02/25/21 Scotiabank
Verizon downgraded to Sector Perform from Outperform at Scotiabank
CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
02/09/21 Benchmark
Comcast price target raised to $70 from $65 at Benchmark
02/03/21
Fly Intel: Top five analyst upgrades
02/03/21 Cowen
Comcast headwinds to dissipate, Cowen upgrades to Outperform
CMCSK Comcast
$0.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
10/07/20 Benchmark
Benchmark would be 'aggressive buyer' of Comcast amid broader market weakness
09/22/20 Benchmark
Comcast price target raised to $60 from $54 at Benchmark
09/16/20 Pivotal Research
Comcast price target raised to $60 from $52 at Pivotal Research
SNE Sony
$104.07 /

+2.22 (+2.18%)

01/12/21 Citi
Sony PS5 sales to date 'steady but somewhat disappointing,' says Citi
12/16/20 Benchmark
Chicken Soup for the Soul price target raised to $25 from $20 at Benchmark
12/16/20 Craig-Hallum
Chicken Soup for the Soul price target raised to $30 from $25 at Craig-Hallum
10/19/20 Credit Suisse
Corsair Gaming initiated with an Outperform at Credit Suisse
LGF.A Lionsgate
$17.31 /

+0.22 (+1.29%)

02/08/21 Deutsche Bank
Lionsgate price target raised to $16 from $12 at Deutsche Bank
02/05/21 RBC Capital
Lionsgate price target raised to $13 from $7 at RBC Capital
01/28/21 Macquarie
Lionsgate price target raised to $18 from $12 at Macquarie
11/10/20 Deutsche Bank
Lionsgate price target raised to $12 from $10 at Deutsche Bank
LGF.B Lionsgate
$14.89 /

+0.21 (+1.43%)

02/05/21 RBC Capital
Lionsgate price target raised to $13 from $7 at RBC Capital
11/02/20 Morgan Stanley
Lionsgate assumed with an Equal Weight at Morgan Stanley
09/02/20 Barrington
Lionsgate price target raised to $14 from $10 at Barrington
05/05/20 Canaccord
Lionsgate price target lowered to $13 from $16 at Canaccord
DIS Disney
$189.90 /

+2.18 (+1.16%)

02/25/21 Craig-Hallum
Magnite price target raised to $72 from $63 at Craig-Hallum
02/25/21 Citi
Disney price target raised to $230 from $205 at Citi
02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
02/17/21 Argus
Disney price target raised to $225 from $200 at Argus
VIACA ViacomCBS
$74.40 /

+2.64 (+3.68%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

03/01/21 Cowen
ViacomCBS price target raised to $46 from $39 at Cowen
02/25/21
Fly Intel: Pre-market Movers
02/25/21 Loop Capital
ViacomCBS cut to Sell at Loop Capital with profitability from streaming unclear
02/25/21 Needham
ViacomCBS price target raised to $80 from $55 at Needham
T AT&T
$29.62 /

+0.705 (+2.44%)

CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SNE Sony
$104.07 /

+2.22 (+2.18%)

LGF.A Lionsgate
$17.31 /

+0.22 (+1.29%)

LGF.B Lionsgate
$14.89 /

+0.21 (+1.43%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

VIACA ViacomCBS
$74.40 /

+2.64 (+3.68%)

VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

T AT&T
$29.62 /

+0.705 (+2.44%)

CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SNE Sony
$104.07 /

+2.22 (+2.18%)

LGF.A Lionsgate
$17.31 /

+0.22 (+1.29%)

LGF.B Lionsgate
$14.89 /

+0.21 (+1.43%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

VIACA ViacomCBS
$74.40 /

+2.64 (+3.68%)

VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

T AT&T
$29.62 /

+0.705 (+2.44%)

CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

SNE Sony
$104.07 /

+2.22 (+2.18%)

LGF.A Lionsgate
$17.31 /

+0.22 (+1.29%)

LGF.B Lionsgate
$14.89 /

+0.21 (+1.43%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

VIACA ViacomCBS
$74.40 /

+2.64 (+3.68%)

VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

T AT&T
$29.62 /

+0.705 (+2.44%)

CMCSA Comcast
$55.03 /

+1.045 (+1.94%)

SNE Sony
$104.07 /

+2.22 (+2.18%)

DIS Disney
$189.90 /

+2.18 (+1.16%)

VIAC ViacomCBS
$74.22 /

+2.35 (+3.27%)

Periodicals
Biden sees $1,400 payments starting to go out this month, Reuters says » 17:50
03/07/21
03/07
17:50
03/07/21
17:50
SPY

SPDR S&P 500 ETF Trust

$383.60 /

+6.87 (+1.82%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

President Joe Biden said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$383.60 /

+6.87 (+1.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$383.60 /

+6.87 (+1.82%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPX S&P 500
$0.00 /

+ (+0.00%)

01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$383.60 /

+6.87 (+1.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$383.60 /

+6.87 (+1.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$383.60 /

+6.87 (+1.82%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Periodicals
Austria suspends AstraZeneca COVID vaccine batch after death, Reuters says » 17:38
03/07/21
03/07
17:38
03/07/21
17:38
AZN

AstraZeneca

$48.05 /

+0.79 (+1.67%)

Austrian authorities have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

AZN AstraZeneca
$48.05 /

+0.79 (+1.67%)

Periodicals
White House urges action despite Microsoft patch amid active threat, Reuters says » 17:32
03/07/21
03/07
17:32
03/07/21
17:32
MSFT

Microsoft

$231.58 /

+4.72 (+2.08%)

The White House urged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

03/05/21 Morgan Stanley
Microsoft price target raised to $290 from $285 at Morgan Stanley
03/03/21 Citi
Microsoft assumed with a Buy at Citi
02/16/21 Wedbush
Microsoft price target raised to $300 from $285 at Wedbush
02/16/21 UBS
Workday price target raised to $280 from $235 at UBS
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

Hot Stocks
Moderna to provide 13M doses of COVID vaccine to Philippines » 16:21
03/07/21
03/07
16:21
03/07/21
16:21
MRNA

Moderna

$132.22 /

+0.01 (+0.01%)

Moderna has announced a…

Moderna has announced a supply agreement with the Government of The Philippines for 13M doses of the COVID-19 Vaccine Moderna. Under the terms of this agreement, deliveries would begin in mid-2021. The COVID-19 Vaccine Moderna is not currently approved for use in the Philippines, and the company will work with regulators to pursue necessary approvals prior to distribution. A separate agreement with the Philippine Government and private sector for the supply of an additional 7M doses is also anticipated.

ShowHide Related Items >><<
MRNA Moderna
$132.22 /

+0.01 (+0.01%)

MRNA Moderna
$132.22 /

+0.01 (+0.01%)

03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
02/26/21 Brookline
Moderna price target raised to $205 from $180 at Brookline
02/25/21 Piper Sandler
Moderna transitioning into profitable company, says Piper Sandler
MRNA Moderna
$132.22 /

+0.01 (+0.01%)

  • 19
    May
MRNA Moderna
$132.22 /

+0.01 (+0.01%)

MRNA Moderna
$132.22 /

+0.01 (+0.01%)

MRNA Moderna
$132.22 /

+0.01 (+0.01%)

Hot Stocks
Gilead announces data from OLE of two Phase 3 studies of Biktarvy » 16:18
03/07/21
03/07
16:18
03/07/21
16:18
GILD

Gilead

$64.62 /

+1.39 (+2.20%)

Gilead Sciences announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$64.62 /

+1.39 (+2.20%)

GILD Gilead
$64.62 /

+1.39 (+2.20%)

02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
02/11/21 Maxim
Galapagos downgraded to Hold at Maxim after discontinued Phase 3 ISABELA trials
02/10/21 Maxim
Maxim downgrades Galapagos after idiopathic pulmonary fibrosis failure
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
GILD Gilead
$64.62 /

+1.39 (+2.20%)

GILD Gilead
$64.62 /

+1.39 (+2.20%)

GILD Gilead
$64.62 /

+1.39 (+2.20%)

GILD Gilead
$64.62 /

+1.39 (+2.20%)

Hot Stocks
Atea Pharmaceuticals presents Phase 1 results for AT-527 » 16:13
03/07/21
03/07
16:13
03/07/21
16:13
AVIR

Atea Pharmaceuticals

$59.98 /

-2.87 (-4.57%)

Atea Pharmaceuticals…

Atea Pharmaceuticals presented results from the Phase 1 study of AT-527 in healthy volunteers at the 28th Annual Conference on Retroviruses and Opportunistic Infections in a Science Spotlight presentation. AT-527 is an orally administered, direct-acting antiviral developmental agent derived from Atea's purine nucleotide prodrug platform and is in Phase 2 clinical development for the treatment of COVID-19. AT-527 targets SARS-CoV-2 ribonucleic acid polymerase, a highly conserved gene which is responsible for both viral RNA replication and transcription. Given this preferential conserved target site, it is anticipated that the antiviral activity of AT-527 will continue even in the presence of naturally-evolving variants which are now emerging. In the Phase 1 study, 20 healthy volunteers were randomized 1:1 to receive oral AT-527 550 mg twice daily or matching placebo for 5 days. The purpose of this study was to assess the safety and pharmacokinetics of AT-527 in healthy volunteers and to predict human lung exposure of intracellular AT-9010, the active triphosphate metabolite of AT-527. Safety assessments included adverse events, vital signs, electrocardiograms, and standard safety laboratory tests. Intensive PK sampling, performed after the first and last two doses, provided information on plasma exposures of AT-511, the free base of AT-527, a hemisulfate salt, and its metabolites including AT-273, the guanosine nucleoside metabolite, a measurable surrogate for intracellular AT-9010. The study results showed AT-527 was well tolerated with a favorable safety profile. There were no discontinuations, serious AEs, clinically significant changes in vital signs, or ECGs observed. The data also demonstrated that AT-511 was rapidly absorbed, followed by fast and extensive stepwise metabolic activation ultimately to the intracellular TP metabolite AT-9010, reflected by plasma AT-273. AT-527 550 mg BID led to fast attainment of steady-state levels of AT-273 within two days of dosing. Plasma levels of AT-273 were further used to predict lung concentrations of AT-9010 using a scaling factor of 1.2X which was previously determined from in vivo tissue distribution of the triphosphate metabolite in cynomolgus monkeys. Beginning as early as three hours after the first dose, and maintained thereafter throughout the five days of dosing, predicted lung AT-9010 levels were consistently above the EC90 level of 0.5 microM for in vitro inhibition by the drug of SARS-CoV-2 replication. These results indicate the potential of AT-527 for the treatment of COVID-19 and are supportive of the dosing regimen of 550 mg BID.

ShowHide Related Items >><<
AVIR Atea Pharmaceuticals
$59.98 /

-2.87 (-4.57%)

AVIR Atea Pharmaceuticals
$59.98 /

-2.87 (-4.57%)

01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
11/24/20 Morgan Stanley
Atea Pharmaceuticals initiated with an Overweight at Morgan Stanley
11/24/20 JPMorgan
Atea Pharmaceuticals initiated with an Overweight at JPMorgan
  • 30
    Oct
AVIR Atea Pharmaceuticals
$59.98 /

-2.87 (-4.57%)

AVIR Atea Pharmaceuticals
$59.98 /

-2.87 (-4.57%)

Hot Stocks
Ridgeback, Merck announce findings from Phase 2a trial of COVID therapeutic » 16:09
03/07/21
03/07
16:09
03/07/21
16:09
MRK

Merck

$73.10 /

+0.95 (+1.32%)

Merck and Ridgeback…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$73.10 /

+0.95 (+1.32%)

MRK Merck
$73.10 /

+0.95 (+1.32%)

02/25/21 SVB Leerink
Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
02/25/21 Morgan Stanley
Pandion downgraded to Equal Weight from Overweight at Morgan Stanley
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
01/21/21 Wedbush
Scholar Rock price target raised to $66 from $47 at Wedbush
MRK Merck
$73.10 /

+0.95 (+1.32%)

MRK Merck
$73.10 /

+0.95 (+1.32%)

MRK Merck
$73.10 /

+0.95 (+1.32%)

MRK Merck
$73.10 /

+0.95 (+1.32%)

Upgrade
Woolworths Group upgraded to Buy from Neutral at Goldman Sachs » 15:49
03/07/21
03/07
15:49
03/07/21
15:49
WOLWF

Woolworths Group

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Nippon Steel upgraded to Conviction Buy from Buy at Goldman Sachs » 15:46
03/07/21
03/07
15:46
03/07/21
15:46
NISTF

Nippon Steel

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Yusuke Akiyama added Nippon Steel to the firm's Conviction List and reiterates a Buy rating on the shares with a price target of 2,150 yen, up from 2,050 yen. "Robust demand" in China will lead to a strengthening of Asian steel prices, says the analyst, who sees a "strong possibility" that the Chinese government will continue to curb steel production capacity and place more stringent restrictions on output in 2021.

ShowHide Related Items >><<
NISTF Nippon Steel
$0.00 /

+ (+0.00%)

07/31/20 Goldman Sachs
Nippon Steel upgraded to Buy from Neutral at Goldman Sachs
Upgrade
Kobe Steel upgraded to Neutral from Sell at Goldman Sachs » 15:44
03/07/21
03/07
15:44
03/07/21
15:44
KBSTF

Kobe Steel

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBSTF Kobe Steel
$0.00 /

+ (+0.00%)

02/22/21 Mizuho
Kobe Steel upgraded to Buy from Neutral at Mizuho
07/31/20 Goldman Sachs
Kobe Steel downgraded to Sell from Neutral at Goldman Sachs
Upgrade
Larsen & Toubro upgraded to Conviction Buy from Buy at Goldman Sachs » 15:41
03/07/21
03/07
15:41
03/07/21
15:41
LTOUF

Larsen & Toubro

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Pulkit Patni added Larsen & Toubro to the firm's Conviction List and reiterates a Buy rating on the shares with a price target of INR 2,055, up from INR 1,650. The Union budget increased confidence on the continuity of government spending, which, along with rising capacity utilization for the manufacturing industry and the "Make in India" initiative bode well for Larsen & Toubro, Patni tells investors in a research note.

ShowHide Related Items >><<
LTOUF Larsen & Toubro
$0.00 /

+ (+0.00%)

10/06/20 ICICI Securities
Larsen & Toubro upgraded to Buy from Add at ICICI Securities
07/17/20 Investec
Larsen & Toubro downgraded to Hold from Buy at Investec
On The Fly
Opening Day: InnovAge rises, Oscar Health slips on first trading day » 09:14
03/07/21
03/07
09:14
03/07/21
09:14
INNV

InnovAge

$25.16 /

+1 (+4.14%)

, OSCR

Oscar Health

$31.01 /

-1.02 (-3.19%)

, VPCC

VPC Impact Acquisition Holdings III

$0.00 /

+ (+0.00%)

, VPCB

VPC Impact Acquisition Holdings II

$0.00 /

+ (+0.00%)

, WPCA

Warburg Pincus Capital Corporation I-A

$0.00 /

+ (+0.00%)

, ATVC

Tribe Capital Growth Corp I

$0.00 /

+ (+0.00%)

, WPCB

Warburg Pincus Capital Corporation I-B

$0.00 /

+ (+0.00%)

, DMYQ

dMY Technology Group IV

$0.00 /

+ (+0.00%)

, TWNT

Tailwind Two Acquisition

$0.00 /

+ (+0.00%)

, FRSG

First Reserve Sustainable Growth

$0.00 /

+ (+0.00%)

, IPVI

InterPrivate IV InfraTech Partners

$0.00 /

+ (+0.00%)

, IPVF

InterPrivate III Financial Partners

$0.00 /

+ (+0.00%)

, IPVA

InterPrivate II Acquisition

$0.00 /

+ (+0.00%)

, PSAGU

Property Solutions Acquisition II

$10.00 /

+0.04 (+0.40%)

, KVSA

Khosla Ventures Acquisition

$10.69 /

+0.43 (+4.19%)

, AURC

Aurora Acquisition

$0.00 /

+ (+0.00%)

, ATAQ

Altimar Acquisition Corp. III

$0.00 /

+ (+0.00%)

, TRCA

Twin Ridge Capital Acquisition

$0.00 /

+ (+0.00%)

, ISOS

Isos Acquisition

$0.00 /

+ (+0.00%)

, MACC

Mission Advancement

$0.00 /

+ (+0.00%)

, ROCR

Roth CH Acquisition III

$0.00 /

+ (+0.00%)

, DHBC

DHB Capital

$0.00 /

+ (+0.00%)

, GBRG

Goldenbridge Acquisition

$0.00 /

+ (+0.00%)

, TSPQ

TCW Special Purpose Acquisition

$0.00 /

+ (+0.00%)

, FTEV

FinTech Evolution Acquisition

$0.00 /

+ (+0.00%)

, SNII

Supernova Partners Acquisition II

$0.00 /

+ (+0.00%)

, OPHA

Orion Acquisition

$0.00 /

+ (+0.00%)

, NDAC

NightDragon Acquisition

$0.00 /

+ (+0.00%)

, ANZU

Anzu Special Acquisition Corp I

$0.00 /

+ (+0.00%)

, NSTD

Northern Star Investment Corp. IV

$0.00 /

+ (+0.00%)

, NSTC

Northern Star Investment Corp. III

$0.00 /

+ (+0.00%)

, LOKM

Live Oak Mobility Acquisition

$0.00 /

+ (+0.00%)

, AMPI

Advanced Merger Partners

$0.00 /

+ (+0.00%)

, COIN

Coinbase

$0.00 /

+ (+0.00%)

, RBLX

Roblox

$0.00 /

+ (+0.00%)

, VZIO

Vizio

$0.00 /

+ (+0.00%)

, GROY

Gold Royalty

$0.00 /

+ (+0.00%)

, ALHC

Alignment Healthcare

$0.00 /

+ (+0.00%)

, HOOD

Robinhood

$0.00 /

+ (+0.00%)

, PLTR

Palantir

$23.92 /

-0.83 (-3.35%)

, ASAN

Asana

$30.61 /

-0.04 (-0.13%)

, WORK

Slack Technologies

$40.44 /

+0.465 (+1.16%)

, SPOT

Spotify

$274.70 /

-10.14 (-3.56%)

, BABA

Alibaba

$233.65 /

+3.575 (+1.55%)

Elder-care company…

ShowHide Related Items >><<
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

INNV InnovAge
$25.16 /

+1 (+4.14%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

VPCC VPC Impact Acquisition Holdings III
$0.00 /

+ (+0.00%)

VPCB VPC Impact Acquisition Holdings II
$0.00 /

+ (+0.00%)

WPCA Warburg Pincus Capital Corporation I-A
$0.00 /

+ (+0.00%)

ATVC Tribe Capital Growth Corp I
$0.00 /

+ (+0.00%)

WPCB Warburg Pincus Capital Corporation I-B
$0.00 /

+ (+0.00%)

DMYQ dMY Technology Group IV
$0.00 /

+ (+0.00%)

TWNT Tailwind Two Acquisition
$0.00 /

+ (+0.00%)

FRSG First Reserve Sustainable Growth
$0.00 /

+ (+0.00%)

IPVI InterPrivate IV InfraTech Partners
$0.00 /

+ (+0.00%)

IPVF InterPrivate III Financial Partners
$0.00 /

+ (+0.00%)

IPVA InterPrivate II Acquisition
$0.00 /

+ (+0.00%)

PSAGU Property Solutions Acquisition II
$10.00 /

+0.04 (+0.40%)

KVSA Khosla Ventures Acquisition
$10.69 /

+0.43 (+4.19%)

AURC Aurora Acquisition
$0.00 /

+ (+0.00%)

ATAQ Altimar Acquisition Corp. III
$0.00 /

+ (+0.00%)

TRCA Twin Ridge Capital Acquisition
$0.00 /

+ (+0.00%)

ISOS Isos Acquisition
$0.00 /

+ (+0.00%)

MACC Mission Advancement
$0.00 /

+ (+0.00%)

ROCR Roth CH Acquisition III
$0.00 /

+ (+0.00%)

DHBC DHB Capital
$0.00 /

+ (+0.00%)

GBRG Goldenbridge Acquisition
$0.00 /

+ (+0.00%)

TSPQ TCW Special Purpose Acquisition
$0.00 /

+ (+0.00%)

FTEV FinTech Evolution Acquisition
$0.00 /

+ (+0.00%)

SNII Supernova Partners Acquisition II
$0.00 /

+ (+0.00%)

OPHA Orion Acquisition
$0.00 /

+ (+0.00%)

NDAC NightDragon Acquisition
$0.00 /

+ (+0.00%)

ANZU Anzu Special Acquisition Corp I
$0.00 /

+ (+0.00%)

NSTD Northern Star Investment Corp. IV
$0.00 /

+ (+0.00%)

NSTC Northern Star Investment Corp. III
$0.00 /

+ (+0.00%)

LOKM Live Oak Mobility Acquisition
$0.00 /

+ (+0.00%)

AMPI Advanced Merger Partners
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 DA Davidson
Coinbase initiated with a Buy at DA Davidson
RBLX Roblox
$0.00 /

+ (+0.00%)

VZIO Vizio
$0.00 /

+ (+0.00%)

GROY Gold Royalty
$0.00 /

+ (+0.00%)

ALHC Alignment Healthcare
$0.00 /

+ (+0.00%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

02/17/21
Fly Intel: Top five analyst upgrades
02/17/21 RBC Capital
Palantir price target raised to $27 from $15 at RBC Capital
02/17/21 Jefferies
Palantir 'a highly unique story for long-term investors,' says Jefferies
02/17/21 Morgan Stanley
Palantir price target raised to $19 from $17 at Morgan Stanley
ASAN Asana
$30.61 /

-0.04 (-0.13%)

03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Baird
Asana initiated with an Outperform, $40 price target at Baird
03/04/21 Baird
Asana initiated with an Outperform at Baird
01/15/21 Credit Suisse
Asana assumed with a Neutral at Credit Suisse
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

03/05/21 DA Davidson
Slack Technologies price target lowered to $40 from $46 at DA Davidson
12/09/20 Morgan Stanley
Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley
12/09/20 Canaccord
Salesforce valuation compelling especially on pullback, says Canaccord
12/09/20 Morgan Stanley
Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
SPOT Spotify
$274.70 /

-10.14 (-3.56%)

02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 JPMorgan
Spotify price target raised to $385 from $350 at JPMorgan
02/23/21 Atlantic Equities
Spotify downgraded to Neutral from Overweight at Atlantic Equities
02/10/21 Pivotal Research
Spotify price target raised to $340 from $260 at Pivotal Research
BABA Alibaba
$233.65 /

+3.575 (+1.55%)

02/23/21 Credit Suisse
Farfetch price target raised to $85 from $53 at Credit Suisse
02/03/21 Raymond James
Alibaba price target raised to $350 from $330 at Raymond James
02/03/21 Mizuho
Alibaba price target raised to $285 from $270 at Mizuho
02/03/21 Macquarie
Alibaba price target raised to $395 from $387 at Macquarie
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

  • 11
    Mar
  • 04
    Mar
  • 03
    Mar
WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

VZIO Vizio
$0.00 /

+ (+0.00%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

RBLX Roblox
$0.00 /

+ (+0.00%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

OSCR Oscar Health
$31.01 /

-1.02 (-3.19%)

HOOD Robinhood
$0.00 /

+ (+0.00%)

COIN Coinbase
$0.00 /

+ (+0.00%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

WORK Slack Technologies
$40.44 /

+0.465 (+1.16%)

SPOT Spotify
$274.70 /

-10.14 (-3.56%)

PLTR Palantir
$23.92 /

-0.83 (-3.35%)

BABA Alibaba
$233.65 /

+3.575 (+1.55%)

ASAN Asana
$30.61 /

-0.04 (-0.13%)

Conference/Events
Super Micro Computer participates in a conference call with Northland » 16:53
03/06/21
03/06
16:53
03/06/21
16:53
SMCI

Super Micro Computer

$33.99 /

+1.38 (+4.23%)

Conference call with CFO…

Conference call with CFO Weigand will be held on March 12 at 12 pm. Webcast Link

ShowHide Related Items >><<
SMCI Super Micro Computer
$33.99 /

+1.38 (+4.23%)

SMCI Super Micro Computer
$33.99 /

+1.38 (+4.23%)

06/11/20 Northland
Super Micro Computer initiated with an Outperform at Northland
06/05/20
Fly Intel: Top five analyst initiations
06/05/20 Loop Capital
Super Micro Computer initiated with a Buy at Loop Capital
06/04/20 Loop Capital
Super Micro Computer initiated with a Buy at Loop Capital
SMCI Super Micro Computer
$33.99 /

+1.38 (+4.23%)

SMCI Super Micro Computer
$33.99 /

+1.38 (+4.23%)

Conference/Events
Accuray participates in a conference call with Northland » 16:51
03/06/21
03/06
16:51
03/06/21
16:51
ARAY

Accuray

$5.08 /

+0.14 (+2.83%)

Cconference call with…

Cconference call with President & CEO Levine and CCO Winter will be held on March 15 at 12 pm. Webcast Link

ShowHide Related Items >><<
ARAY Accuray
$5.08 /

+0.14 (+2.83%)

ARAY Accuray
$5.08 /

+0.14 (+2.83%)

01/07/21
Fly Intel: Top five analyst initiations
01/07/21 Northland
Accuray initiated with an Outperform at Northland
09/28/20 Lake Street
CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street
09/18/20 Cowen
New CMS model should provide tailwind for Accuray, says Cowen
ARAY Accuray
$5.08 /

+0.14 (+2.83%)

ARAY Accuray
$5.08 /

+0.14 (+2.83%)

Periodicals
Cisco, Qualcomm offer solid yield, dividend growth, Barron's says » 12:36
03/06/21
03/06
12:36
03/06/21
12:36
AVGO

Broadcom

$449.96 /

+6.555 (+1.48%)

, CSCO

Cisco

$46.22 /

+1.595 (+3.57%)

, QCOM

Qualcomm

$129.75 /

+2.0799 (+1.63%)

, TXN

Texas Instruments

$167.83 /

+4.58 (+2.81%)

It's hard to find…

It's hard to find attractive yields with dividend growth among tech stock but Broadcom (AVGO), Cisco (CSCO), Qualcomm (QCOM) and Texas Instruments (TXN) offer both, Lawrence Strauss writes on this week's edition of Barron's. Reference Link

ShowHide Related Items >><<
TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

03/05/21 JPMorgan
Broadcom price target raised to $570 from $500 at JPMorgan
03/05/21 Morgan Stanley
Broadcom price target raised to $538 from $521 at Morgan Stanley
03/05/21 RBC Capital
Broadcom price target raised to $460 from $450 at RBC Capital
03/05/21 Wells Fargo
Broadcom price target raised to $450 from $410 at Wells Fargo
CSCO Cisco
$46.22 /

+1.595 (+3.57%)

03/05/21
Fly Intel: Top five analyst upgrades
03/05/21 JPMorgan
JPMorgan upgrades Cisco on spending recovery, 'inexpensive' valuation
03/05/21 JPMorgan
Cisco upgraded to Overweight from Neutral at JPMorgan
02/11/21 DZ Bank
Cisco upgraded to Buy from Hold at DZ Bank
QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

03/04/21
Fly Intel: Top five analyst upgrades
03/04/21 JPMorgan
Qualcomm price target lowered to $170 from $185 at JPMorgan
03/04/21 Piper Sandler
Qualcomm upgraded to Overweight from Neutral at Piper Sandler
02/10/21 JPMorgan
China mobile shipments data point to 'robust' Apple demand, says JPMorgan
TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

02/23/21
Fly Intel: Top five analyst upgrades
02/23/21 Raymond James
Texas Instruments upgraded to Outperform from Market Perform at Raymond James
02/23/21 Raymond James
Texas Instruments upgraded to Outperform from Market Perform at Raymond James
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

TXN Texas Instruments
$167.83 /

+4.58 (+2.81%)

QCOM Qualcomm
$129.75 /

+2.0799 (+1.63%)

CSCO Cisco
$46.22 /

+1.595 (+3.57%)

AVGO Broadcom
$449.96 /

+6.555 (+1.48%)

Periodicals
Vertex underperformance after drug setback a buying opportunity, Barron's says » 12:19
03/06/21
03/06
12:19
03/06/21
12:19
VRTX

Vertex Pharmaceuticals

$211.97 /

+4.14 (+1.99%)

For nearly a decade,…

For nearly a decade, Vertex Pharmaceuticals could do no wrong but then the biotech company canceled development of a once-promising drug after trial results disappointed and its stock is now down 25% since mid-October, Josh Nathan-Kazis writes in this week's edition of Barron's. The pullback has been overdone, the author contends, adding that there is an opportunity now for investors to get back in. Reference Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

02/23/21 Baird
Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
02/23/21 Baird
Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
02/02/21 Credit Suisse
Vertex Pharmaceuticals price target lowered to $280 from $285 at Credit Suisse
02/02/21 BMO Capital
Vertex Pharmaceuticals price target lowered to $284 from $302 at BMO Capital
VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

VRTX Vertex Pharmaceuticals
$211.97 /

+4.14 (+1.99%)

Periodicals
Lowe's can win reopening, stock a buy, Barron's says » 12:12
03/06/21
03/06
12:12
03/06/21
12:12
LOW

Lowe's

$158.56 /

+4.865 (+3.17%)

Lowe's was a…

Lowe's was a lockdown winner and investors are having second thoughts about its stock now that reopening looms, but Lowe's is far more than just a COVID-19 play, Teresa Rivas writes in this week's edition of Barron's. Concerns are probably overblown and with COVID receding, Lowe's is set to become a more profitable company, while housing might be more resilient than it's given credit for, the author contends. Reference Link

ShowHide Related Items >><<
LOW Lowe's
$158.56 /

+4.865 (+3.17%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 Gordon Haskett
Gordon Haskett upgrades Lowe's to Buy, sees ability to 'stomp the comp'
02/25/21 Gordon Haskett
Lowe's upgraded to Buy from Accumulate at Gordon Haskett
02/24/21 RBC Capital
Lowe's price target raised to $206 after quarterly results at RBC Capital
LOW Lowe's
$158.56 /

+4.865 (+3.17%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

LOW Lowe's
$158.56 /

+4.865 (+3.17%)

Periodicals
MyTheresa stock might be cheapest thing it sells, Barron's says » 12:01
03/06/21
03/06
12:01
03/06/21
12:01
MYTE

Mytheresa

$27.08 /

+1.9 (+7.55%)

Mytheresa stock -…

Mytheresa stock - technically an American depositary share of parent company MYT Netherlands Parent - was recently trading just below its $26 initial-public-offering price after having jumped to $36 shortly after the debut, Nicholas Jasinski writes in this week's edition of Barron's. The stock could recover those losses and more in the coming months, the author contends, noting that while luxury buyer might have been slower to adopt e-commerce, the overall luxury market is growing by about 7% annually. Reference Link

ShowHide Related Items >><<
MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

02/16/21
Fly Intel: Top five analyst initiations
02/16/21 Jefferies
Mytheresa initiated with a Buy at Jefferies
02/16/21 Credit Suisse
Mytheresa initiated with an Outperform at Credit Suisse
02/16/21 Morgan Stanley
Mytheresa initiated with an Overweight at Morgan Stanley
  • 21
    Jan
MYTE Mytheresa
$27.08 /

+1.9 (+7.55%)

Initiation
Cloopen initiated with a Neutral at Goldman Sachs » 09:57
03/06/21
03/06
09:57
03/06/21
09:57
RAAS

Cloopen

$19.82 /

+1.97 (+11.04%)

Goldman Sachs analyst…

Goldman Sachs analyst Tina Hou initiated coverage of Cloopen Group Holding with a Neutral rating and $16.20 price target, implying 9% downside. Cloopen is China's largest multi-capability cloud-based communications solution provider by revenues with with 12,000 active customers as of Q3, Hou tells investors in a research note. The analyst likes Cloopen's "ample" market opportunities and "comprehensive" product offering, but believes current valuations already reflect the stock's long-term growth potential.

ShowHide Related Items >><<
  • 09
    Feb
RAAS Cloopen
$19.82 /

+1.97 (+11.04%)

Initiation
Adagene initiated with a Buy at Goldman Sachs » 09:55
03/06/21
03/06
09:55
03/06/21
09:55
ADAG

Adagene

$23.05 /

+0.39 (+1.72%)

Goldman Sachs analyst…

Goldman Sachs analyst Ziyi Chen initiated coverage of Adagene with a Buy rating and $29 price target, which represents 26% upside. Adagene is a pre-revenue biotech company with a proprietary antibody drug discovery platform, Chen tells investors in a research note. The analyst believes Adagene has the potential to "revolutionize antibody drug discovery" if its dynamic precision library platform is fully validated. Chen sees "multiple value-driving catalysts" in 2021.

ShowHide Related Items >><<
  • 09
    Feb
ADAG Adagene
$23.05 /

+0.39 (+1.72%)

On The Fly
Charged: GM-backed Cruise said to be in talks to acquire Voyage » 07:31
03/06/21
03/06
07:31
03/06/21
07:31
TSLA

Tesla

$597.45 /

-24.41 (-3.93%)

, NIO

NIO

$38.13 /

-1.135 (-2.89%)

, XPEV

Xpeng

$28.05 /

-1.38 (-4.69%)

, F

Ford

$12.27 /

+0.335 (+2.81%)

, LI

Li Auto

$22.48 /

+0.16 (+0.72%)

, GM

General Motors

$53.75 /

+1.92 (+3.70%)

, FSR

Fisker

$21.30 /

-1.23 (-5.46%)

, QS

QuantumScape

$44.40 /

+0.5 (+1.14%)

, PLUG

Plug Power

$39.25 /

-0.75 (-1.88%)

, NEE

NextEra Energy

$70.72 /

-0.56 (-0.79%)

Welcome to The Fly's…

ShowHide Related Items >><<
XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

QS QuantumScape
$44.40 /

+0.5 (+1.14%)

PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

LI Li Auto
$22.48 /

+0.16 (+0.72%)

GM General Motors
$53.75 /

+1.92 (+3.70%)

FSR Fisker
$21.30 /

-1.23 (-5.46%)

F Ford
$12.27 /

+0.335 (+2.81%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

03/03/21 Morgan Stanley
Mustang Mach-E took major Tesla EV share in February, says Morgan Stanley
03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
02/25/21 Wedbush
Wedbush sees limited impact to Tesla from chip-driven factory shutdowns
02/22/21 Wedbush
Wedbush estimates Tesla made roughly $1B on bitcoin investment
NIO NIO
$38.13 /

-1.135 (-2.89%)

02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

01/28/21
Morgan Stanley starts Xpeng at Overweight on in-house R&D, market potential
01/28/21 Morgan Stanley
Xpeng initiated with an Overweight at Morgan Stanley
01/21/21 Deutsche Bank
Deutsche puts short-term buy on Xpeng ahead of 'several catalysts'
F Ford
$12.27 /

+0.335 (+2.81%)

02/24/21 Roth Capital
Roth cuts Workhorse target to $15 after 'highly unusual' contract loss
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
02/09/21
Fly Intel: Top five analyst upgrades
LI Li Auto
$22.48 /

+0.16 (+0.72%)

02/26/21 Daiwa
Li Auto upgraded to Buy from Hold at Daiwa
02/01/21
Fly Intel: Top five analyst initiations
02/01/21 Deutsche Bank
Deutsche starts Li Auto with Hold, awaits clarity on roadmap
GM General Motors
$53.75 /

+1.92 (+3.70%)

02/19/21 Morgan Stanley
GM's 'hidden gems' drawing rising investor interest, says Morgan Stanley
02/18/21 Citi
General Motors price target raised to $85 from $70 at Citi
02/11/21 RBC Capital
General Motors price target raised to $67 from $52 at RBC Capital
FSR Fisker
$21.30 /

-1.23 (-5.46%)

03/03/21 Wolfe Research
Wolfe upgrades Fisker, says Foxconn deal 'changed the narrative'
03/03/21 Wolfe Research
Fisker upgraded to Peer Perform from Underperform at Wolfe Research
02/26/21 Morgan Stanley
Fisker price target raised to $40 from $27 at Morgan Stanley
02/26/21 Cowen
Fisker price target raised to $29 from $22 at Cowen
QS QuantumScape
$44.40 /

+0.5 (+1.14%)

03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
02/04/21 Goldman Sachs
QuantumScape initiated with a Neutral at Goldman Sachs
11/30/20
Fly Intel: Top five analyst initiations
PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

03/05/21 JPMorgan
Plug Power price target lowered to $61 from $65 at JPMorgan
03/02/21
Fly Intel: Top five analyst downgrades
03/02/21 Barclays
Plug Power downgraded to Underweight from Equal Weight at Barclays
03/01/21
Fly Intel: Top five analyst upgrades
NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

03/03/21 Bernstein
NextEra Energy initiated with an Outperform at Bernstein
01/27/21 Credit Suisse
NextEra Energy price target raised to $87 from $77 at Credit Suisse
01/27/21 Wells Fargo
NextEra Energy price target raised to $100 from $85 at Wells Fargo
01/20/21 Credit Suisse
NextEra Energy Partners price target raised to $86 from $71 at Credit Suisse
XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

LI Li Auto
$22.48 /

+0.16 (+0.72%)

GM General Motors
$53.75 /

+1.92 (+3.70%)

FSR Fisker
$21.30 /

-1.23 (-5.46%)

F Ford
$12.27 /

+0.335 (+2.81%)

  • 27
    Jan
  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
  • 17
    Nov
  • 31
    Aug
  • 27
    Aug
  • 12
    Aug
  • 30
    Jul
  • 11
    Jun
XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

QS QuantumScape
$44.40 /

+0.5 (+1.14%)

PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

GM General Motors
$53.75 /

+1.92 (+3.70%)

FSR Fisker
$21.30 /

-1.23 (-5.46%)

F Ford
$12.27 /

+0.335 (+2.81%)

XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

QS QuantumScape
$44.40 /

+0.5 (+1.14%)

PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

LI Li Auto
$22.48 /

+0.16 (+0.72%)

GM General Motors
$53.75 /

+1.92 (+3.70%)

FSR Fisker
$21.30 /

-1.23 (-5.46%)

F Ford
$12.27 /

+0.335 (+2.81%)

XPEV Xpeng
$28.05 /

-1.38 (-4.69%)

TSLA Tesla
$597.45 /

-24.41 (-3.93%)

QS QuantumScape
$44.40 /

+0.5 (+1.14%)

PLUG Plug Power
$39.25 /

-0.75 (-1.88%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NEE NextEra Energy
$70.72 /

-0.56 (-0.79%)

LI Li Auto
$22.48 /

+0.16 (+0.72%)

GM General Motors
$53.75 /

+1.92 (+3.70%)

FSR Fisker
$21.30 /

-1.23 (-5.46%)

F Ford
$12.27 /

+0.335 (+2.81%)

General news
Treasury Market Summary » 19:05
03/05/21
03/05
19:05
03/05/21
19:05

Treasury Market Summary:…

Treasury Market Summary: nonfarm payrolls bolted 379k higher and the blowout jobs report made for some big swings in the markets before both bonds and stocks settled into gains in late day trading. The markets were volatile but not disorderly and the relative calm was beneficial in general. Treasury yields shot higher with longer dated maturities breaching the February 25 intraday highs to post the cheapest rates in over a year. The wi 10-year rose over 6 bps to test 1.624% before slipping back to 1.57% at the close. The wi 30-year bond was 2 bps lower at 2.305%, and the 2-year was down 0.8 bps to 0.137%. Wall Street was knocked lower again in reaction to the rise in rates, as has been the recent trend. The S&P 500 dropped -1% to hit 3730 before dip buying emerged, supported by a "good news is good news" trade. All of the indexes climbed through the afternoon with the S&P 500 leading the rally, finishing 1.95% firmer at 3841 to boost the index 1% higher to 3823. The Dow rose 1.85% to 31,496. And after lagging much of the session, the NASDAQ closed up 1.55% to 12,920. View the summary.

Hot Stocks
Ellington Financial reports estimated book value per share of $18.06 on Feb 28 » 19:00
03/05/21
03/05
19:00
03/05/21
19:00
EFC

Ellington Financial

$15.80 /

-0.03 (-0.19%)

The company announced its…

The company announced its estimated book value per common share of $18.06 as of February 28. This estimate includes the effect of the previously announced monthly dividend of 10c per common share, payable on March 25 to holders of record on February 26, with an ex-dividend date of February 25.

ShowHide Related Items >><<
EFC Ellington Financial
$15.80 /

-0.03 (-0.19%)

EFC Ellington Financial
$15.80 /

-0.03 (-0.19%)

01/15/21 UBS
Ellington Financial initiated with a Buy at UBS
12/18/20 Keefe Bruyette
Ellington Financial upgraded to Outperform from Market Perform at Keefe Bruyette
11/23/20 BTIG
Ellington Financial initiated with a Buy at BTIG
10/14/20 B. Riley Securities
Ellington Financial price target raised to $14 from $12.50 at B. Riley
EFC Ellington Financial
$15.80 /

-0.03 (-0.19%)

Hot Stocks
Adaptive Biotechnologies says FDA issues EUA for T-Detect COVID » 18:47
03/05/21
03/05
18:47
03/05/21
18:47
ADPT

Adaptive Biotechnologies

$42.20 /

-1.3999 (-3.21%)

, MSFT

Microsoft

$231.58 /

+4.72 (+2.08%)

Adaptive Biotechnologies…

Adaptive Biotechnologies (ADPT) announced that the U.S. FDA issued an Emergency Use Authorization for T-Detect COVID to confirm recent or prior COVID-19 infection. This first-in-class T cell- based test is the first indication resulting from Adaptive's TCR-Antigen Map collaboration with Microsoft (MSFT).

ShowHide Related Items >><<
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

ADPT Adaptive Biotechnologies
$42.20 /

-1.3999 (-3.21%)

ADPT Adaptive Biotechnologies
$42.20 /

-1.3999 (-3.21%)

03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Goldman Sachs
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

03/05/21 Morgan Stanley
Microsoft price target raised to $290 from $285 at Morgan Stanley
03/03/21 Citi
Microsoft assumed with a Buy at Citi
02/16/21 Wedbush
Microsoft price target raised to $300 from $285 at Wedbush
02/16/21 UBS
Workday price target raised to $280 from $235 at UBS
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

ADPT Adaptive Biotechnologies
$42.20 /

-1.3999 (-3.21%)

  • 16
    Jul
MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

ADPT Adaptive Biotechnologies
$42.20 /

-1.3999 (-3.21%)

MSFT Microsoft
$231.58 /

+4.72 (+2.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.